AF AbdelMagid, 1996, J Org Chem, 61, 3849, 10.1021/jo960057x
DW Aswad, 1995, Deamidation and isoaspartate formation in peptides and proteins
L Aurelio, 2000, Aust J Chem, 53, 425, 10.1071/CH99082
L Aurelio, 2002, Org Lett, 4, 3767, 10.1021/ol026799w
L Aurelio, 2003, J Org Chem, 68, 2652, 10.1021/jo026722l
L Aurelio, 2004, Chem Rev, 104, 5823, 10.1021/cr030024z
JF Briere, 1997, Tetrahedron, 53, 2075, 10.1016/S0040-4020(96)01157-X
K Burger, 2000, Eur J Org Chem, 2000, 199, 10.1002/(SICI)1099-0690(200001)2000:1<199::AID-EJOC199>3.0.CO;2-8
K Burger, 1999, Amino Acids, 16, 287, 10.1007/BF01388173
K Burger, 2000, Mh Chemie, 131, 463
S Chamoin, 2003, Chimia, 57, 241, 10.2533/000942903777679370
JJ Chruma, 1997, Tetrahedron Lett, 38, 5085, 10.1016/S0040-4039(97)01132-5
S Clarke, 1992, Stability of protein pharmaceuticals, part A: chemical and physical pathways of protein degradation, 2
A D’Aniello, 2003, FEBS Lett, 552, 193, 10.1016/S0014-5793(03)00921-9
TJ Deming, 1997, Nature, 390, 386, 10.1038/37084
M Ebata, 1966, Bull Chem Soc Jpn, 39, 2535, 10.1246/bcsj.39.2535
M Falorni, 1997, Tetrahedron Lett, 38, 4663, 10.1016/S0040-4039(97)00961-1
GP Gasic, 1992, Annu Rev Physiol, 54, 507, 10.1146/annurev.ph.54.030192.002451
VS Goodfellow, 1996, J Med Chem, 39, 1472, 10.1021/jm950716i
A Hashimoto, 1997, Prog Neurobiol, 52, 325, 10.1016/S0301-0082(97)00019-1
C Howes, 1983, J Chem Soc Perkin Trans, 1, 2287, 10.1039/p19830002287
AR Katritzky, 1998, Heterocycles, 48, 2677, 10.3987/REV-98-506
WR Li, 1992, Studies in natural products chemistry, 241
Y Liwschitz, 1954, J Am Chem Soc, 76, 3698, 10.1021/ja01643a030
Y Liwschitz, 1956, J Am Chem Soc, 78, 3069, 10.1021/ja01594a034
O Lutz, 1930, Mitteil Chem Ber, 63B, 448, 10.1002/cber.19300630232
J Maddaluno, 1992, Tetrahedron, 3, 1239, 10.1016/S0957-4166(00)82081-9
M Mergler, 2003, J Pept Sci, 9, 36, 10.1002/psc.430
H Mori, 1995, Neuropharmacology, 34, 1219, 10.1016/0028-3908(95)00109-J
Y Nabuchi, 1997, Pharm Res, 14, 1685, 10.1023/A:1012115426306
C Oliyai, 1994, Pharm Res, 11, 751, 10.1023/A:1018944800691
W Oppolzer, 1993, Helv Chim Acta, 76, 187, 10.1002/hlca.19930760113
Orphanides GG (1979) Preparation of maleimides and dimaleimides. U.S. Pat. 4,154,737 (to E. I. du Pont de Nemours Co. Inc.)
J Orpiszewski, 2000, FASEB J, 14, 1255, 10.1096/fasebj.14.9.1255
D Papaioannou, 1994, Acta Chem Scand, 48, 324, 10.3891/acta.chem.scand.48-0324
GR Pettit, 1993, Tetrahedron, 49, 9151, 10.1016/0040-4020(93)80003-C
PS Piispanen, 2005, Tetrahedron Lett, 46, 2751, 10.1016/j.tetlet.2005.02.159
M Prashad, 2003, Org Lett, 5, 125, 10.1021/ol0268440
GV Reddy, 1999, Chem Lett, 28, 299, 10.1246/cl.1999.299
Reppe W, Ufer H (1937) N-substituted aspartic acids and their functional derivatives and process of producing them. 1246815; Patent; I.G.Farbenind. U.S. Patent 2,200,220
AE Roher, 1993, J Biol Chem, 268, 3072, 10.1016/S0021-9258(18)53661-9
M Sato, 1987, Biochem J, 241, 309, 10.1042/bj2410309
H Schedel, 2000, Mh Chemie, 131, 1011
S Sciuto, 1979, Phytochemistry, 18, 1058, 10.1016/S0031-9422(00)91478-X
A Seleni, 2000, FASEB J, 14, 699, 10.1096/fasebj.14.5.699
PA Stadler, 1962, Helv Chim Acta, 45, 2005, 10.1002/hlca.19620450636
JP Tam, 1988, Pept Res, 1, 6
B Thern, 2002, Tetrahedron Lett, 43, 5013, 10.1016/S0040-4039(02)00657-3
Thomas PD (1976) Organic acid derivatives. U.S. Pat. 3,953,616 (to Pfizer Inc.)
N Todoroki, 1999, J Chromatogr, 728B, 41, 10.1016/S0378-4347(99)00089-4
SH van Leeuwen, 2002, Tetrahedron Lett, 43, 9203, 10.1016/S0040-4039(02)02275-X
G Verardo, 2002, Can J Chem, 80, 779, 10.1139/v02-083
B Vitoux, 1986, Int J Pept Protein Res, 27, 617, 10.1111/j.1399-3011.1986.tb01058.x
T Watanabe, 1998, Amino Acids, 14, 353, 10.1007/BF01318854
JC Watkins, 1962, J Med Pharm Chem, 5, 1187, 10.1021/jm01241a010
JC Watkins, 1981, Annu Rev Pharmacol Toxicol, 21, 165, 10.1146/annurev.pa.21.040181.001121
K Wisniewski, 1997, Tetrahedron Lett, 38, 483, 10.1016/S0040-4039(96)02350-7
A Zilkha, 1959, J Org Chem, 24, 1096, 10.1021/jo01090a015
